In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Merz Pharmaceuticals LLC

Division of Merz GmbH & Co. KGaA
www.merzusa.com

Latest From Merz Pharmaceuticals LLC

Keeping Track: CDER Approves Its First Two Novel Agents Of 2019

The latest drug development news and highlights from our US FDA Performance Tracker.
Drug Review Regulation

How Long Does It Take To Change A Name?

Three-month timeframe for nonproprietary name changes of two botulinum toxin products is unlikely to be replicated for the dozens of currently licensed biologics subject to FDA’s requirement for distinguishable suffixes.

Biosimilars Biologics

How Long Does It Take To Change A Name?

Three-month timeframe for nonproprietary name changes of two botulinum toxin products is unlikely to be replicated for the dozens of currently licensed biologics subject to FDA’s requirement for distinguishable suffixes.

Biosimilars Biologics

Serious Injuries Prompt New FDA Labeling Recommendations For Dermal Fillers

FDA urged dermal filler firms to update labeling to warn of rare but serious complications that can occur when the soft tissue products are unintentionally injected into facial blood vessels in conjunction with a safety communication to providers and patients on the topic.

Medical Device Regulation
See All

Company Information

  • Industry
  • Pharmaceuticals
    • OTC, Consumer
  • Therapeutic Areas
  • Dermatology
  • Musculoskeletal & Connective Tissue Disorders
  • Neurology, Nervous System
  • Alias(es)
  • Merz Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Merz GmbH & Co. KGaA
  • Senior Management
  • Bill J Humphries, Pres. & CEO
    Robert W Burgess, CFO & VP, Admin.
    Bhushan Hardas, MD, VP & US Head, R&D
  • Contact Info
  • Merz Pharmaceuticals LLC
    Phone: (888) 637-9872
    P.O. Box 18806 Greensboro, NC 27419
    USA
UsernamePublicRestriction

Register